We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
26
Establishment Labs
ESTA
$2.28B
$17.9M 1.02%
260,966
+135,338
+108% +$9.35M
MTN icon
27
Vail Resorts
MTN
$5.3B
$17.9M 1.02%
71,116
-1,186
-2% -$289K
SSTK icon
28
Shutterstock
SSTK
$219M
$17.8M 1.01%
364,976
-1,370
-0.4% -$78.1K
APPS icon
29
Digital Turbine
APPS
$1.74B
$17.2M 0.97%
1,848,924
-1,889
-0.1% -$20.8K
LMAT icon
30
LeMaitre Vascular
LMAT
$1.86B
$17M 0.96%
252,418
-2,048
-0.8% -$125K
MMS icon
31
Maximus
MMS
$3.1B
$17M 0.96%
200,732
-2,416
-1% -$199K
SUPN icon
32
Supernus Pharmaceuticals
SUPN
$2.77B
$16.7M 0.95%
554,793
+3,508
+0.6% +$123K
POOL icon
33
Pool Corp
POOL
$7.5B
$16.6M 0.94%
44,397
-842
-2% -$288K
ASND icon
34
Ascendis Pharma A/S
ASND
$16.8B
$15.5M 0.88%
173,463
+18,535
+12% +$1.61M
OZK icon
35
Bank OZK
OZK
$5.61B
$14.9M 0.85%
371,216
-6,968
-2% -$250K
OABI icon
36
OmniAb
OABI
$447M
$14.2M 0.81%
2,832,376
+12,274
+0.4% +$49.8K
RVNC
37
DELISTED
Revance Therapeutics, Inc.
RVNC
$14M 0.79%
552,495
-256,681
-32% -$8M
CMBM
38
DELISTED
Cambium Networks
CMBM
$13.9M 0.79%
914,310
+35,937
+4% +$557K
EB
39
DELISTED
Eventbrite
EB
$13.8M 0.78%
1,444,950
+1,235,961
+591% +$9.72M
BCRX icon
40
BioCryst Pharmaceuticals
BCRX
$2.4B
$13.2M 0.75%
+1,872,964
New +$15M
FOLD
41
DELISTED
Amicus Therapeutics
FOLD
$13.2M 0.75%
1,048,663
+201,804
+24% +$2.39M
QLYS icon
42
Qualys
QLYS
$6.35B
$13M 0.74%
100,514
-1,627
-2% -$200K
NBIX icon
43
Neurocrine Biosciences
NBIX
$16.6B
$12.7M 0.72%
135,070
-2,167
-2% -$212K
RBA icon
44
RB Global
RBA
$17.5B
$12.4M 0.7%
206,647
-686
-0.3% -$38.7K
IOVA icon
45
Iovance Biotherapeutics
IOVA
$2.87B
$12.4M 0.7%
1,758,759
+28,795
+2% +$206K
CEVA icon
46
CEVA Inc
CEVA
$1.08B
$12.1M 0.69%
474,622
+717
+0.2% +$18K
PINC
47
DELISTED
Premier
PINC
$11.7M 0.67%
424,759
-386,583
-48% -$11M
TRAK icon
48
ReposiTrak
TRAK
$159M
$11.2M 0.63%
1,108,024
+42,140
+4% +$317K
UTMD icon
49
Utah Medical Products
UTMD
$225M
$10.5M 0.6%
112,999
-1,124
-1% -$106K
CNTY icon
50
Century Casinos
CNTY
$34M
$9.37M 0.53%
1,320,114
+9,829
+0.8% +$69.7K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.